Shi Q, Sobrero AF, Shields AF, Yoshino T

[1] Shi Q, Sobrero AF, Shields AF, Yoshino T, Paul J, Taieb J, Sougklakos I, Kerr R, et al. Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration. J Clin Oncol 35, 2017 (suppl; abstr LBA1).
[2] Key Statistics for Colorectal Cancer. American Cancer Society. Online. https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html Last accessed June 4, 2017.